| 产品名称: | Serratia marcescens Bizio |
|---|---|
| 商品货号: | TS202851 |
| Strain Designations: | 3G |
| Application: | Enteric Research |
| Isolation: | Human blood, Belgium |
| Biosafety Level: | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format: | freeze-dried |
| Storage Conditions: | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Preceptrol®: | no |
| Type Strain: | no |
| Antibiotic Resistance: | Depositors claim multidrug resistance to amikacin, aztreonam, carbenicillin, cefoperazone, cefotaxime, cefoxitin, chloramphenicol, ciprofloxacin, mezlocillin, piperacillin, tetracycline, and tobramycin (see reference). ATCC could confirm antibiotic resistance only to cefoxitin and tobramycin. |
| Comments: | Depositors claim multidrug resistance to amikacin, aztreonam, carbenicillin, cefoperazone, cefotaxime, cefoxitin, chloramphenicol, ciprofloxacin, mezlocillin, piperacillin, tetracycline, and tobramycin (see reference). ATCC could confirm antibiotic resistance only to cefoxitin and tobramycin. |
| Medium: | ATCC® Medium 1522: Trypticase soy medium (ATCC medium 18) with 8 mcg/ml of tobramycin |
| Growth Conditions: | Temperature: 37°C
Atmosphere: Aerobic |
| Name of Depositor: | CC Sanders |
| Chain of Custody: | ATCC |
| References: | Sanders CC, Watanakunakorn C. Emergence of resistance to þ-lactams, aminoglycosides, and quinolones during combination therapy for infection due to Serratia marcescens. J. Infect. Dis. 153: 617-619, 1986. PubMed: 3512733 |